Quercetin inhibits the invasion and mobility of murine melanoma B16-BL6 cells through inducing apoptosis via decreasing Bcl-2 expression

被引:47
作者
Zhang, XM
Xu, Q
Saiki, I
机构
[1] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
[2] Toyama Med & Pharmaceut Univ, Res Inst Wakan Yaku, Dept Pathogen Biochem, Toyama, Japan
基金
中国国家自然科学基金;
关键词
apoptosis; Bcl-2; cell cycle; invasion; metastasis; mobility; melanoma B16-BL6 cells;
D O I
10.1023/A:1010960615370
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Quercetin has been known to have anti-tumor and anti-oxidation activities. In the present study, we have investigated its in vitro anti-metastatic activity. Quercetin inhibited the invasion and mobility of murine melanoma B16-BL6 cells in a dose-dependent manner but did not affect their adhesion to either laminin, fibronectin, or type VI collagen. Moreover, quercetin significantly inhibited the proliferation of B16-BL6 cells only in the case of time incubation longer than 48 h. Quercetin dose-dependently decreased the cell rates in S and G2-M phases of cell cycle. The effect of quercetin to cause a remarkable apoptosis of B16-BL6 cells was also demonstrated by flow cytometric assay as well as DNA fragmentation with a typical 180-bp ladder band in agarose electrophoresis and a quantitative analysis. Furthermore, quercetin markedly inhibited the expression of anti-apoptotic protein Bcl-2 but hardly influenced Bcl-X-L. These results suggest that the inhibition of quercetin on invasiveness and migration of B16-BL6 cells are closely associated with the arrest of cell cycle as well as the induction of apoptosis by decreasing the Bcl-2 expression.
引用
收藏
页码:415 / 421
页数:7
相关论文
共 49 条
[1]   Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3 [J].
Baker, AH ;
George, SJ ;
Zaltsman, AB ;
Murphy, G ;
Newby, AC .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1347-1355
[2]   Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line [J].
Biroccio, A ;
Candiloro, A ;
Mottolese, M ;
Sapora, O ;
Albini, A ;
Zupi, G ;
Del Bufalo, D .
FASEB JOURNAL, 2000, 14 (05) :652-660
[3]   Molecular mechanisms of tumor metastasis and angiogenesis [J].
Böhle, AS ;
Kalthoff, H .
LANGENBECKS ARCHIVES OF SURGERY, 1999, 384 (02) :133-140
[4]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[5]  
CENDAN JC, 1996, ANN SURG ONCOL, V3, P502
[6]  
Cheng JD, 1999, CLIN CANCER RES, V5, P1057
[7]   Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix [J].
Cho, SY ;
Klemke, RL .
JOURNAL OF CELL BIOLOGY, 2000, 149 (01) :223-236
[8]   DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation [J].
Difilippantonio, MJ ;
Zhu, J ;
Chen, HT ;
Meffre, E ;
Nussenzweig, MC ;
Max, EE ;
Ried, T ;
Nussenzweig, A .
NATURE, 2000, 404 (6777) :510-514
[9]  
EMLEN W, 1994, J IMMUNOL, V152, P3685
[10]   Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance [J].
Fernández, Y ;
España, L ;
Mañas, S ;
Fabra, A ;
Sierra, A .
CELL DEATH AND DIFFERENTIATION, 2000, 7 (04) :350-359